Combination of three cytotoxic agents in small-cell lung cancer

PURPOSE: The established treatment for small-cell lung cancer has been a cisplatin–etoposide combination, as the most effective chemotherapy regimen. Paclitaxel has also been used in combination with cisplatin and etoposide but this has been unacceptable due to the toxicity. This toxicity could be a...

Descripción completa

Detalles Bibliográficos
Autores principales: Stathopoulos, G. P., Trafalis, D., Dimitroulis, J., Kosmas, Ch., Stathopoulos, J., Tsavdaridis, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556467/
https://www.ncbi.nlm.nih.gov/pubmed/23161410
http://dx.doi.org/10.1007/s00280-012-2022-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556467/
https://www.ncbi.nlm.nih.gov/pubmed/23161410
http://dx.doi.org/10.1007/s00280-012-2022-8

Ejemplares similares